CRISPR Therapeutics：CASGEVY验证平台价值，强化收购案例
· seekingalpha.com
CRISPR Therapeutics当前56亿美元市值和17.8亿美元净现金头寸使其具有收购吸引力。点击了解为何CRSP被评级为买入。
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) gene editing is one of the most important advances in modern biotechnology, allowing scientis...